These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 18556645

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Strontium ranelate: a novel mode of action leading to renewed bone quality.
    Ammann P.
    Osteoporos Int; 2005 Jan; 16 Suppl 1():S11-5. PubMed ID: 15578157
    [Abstract] [Full Text] [Related]

  • 3. Strontium ranelate in osteoporosis.
    Reginster JY.
    Curr Pharm Des; 2002 Jan; 8(21):1907-16. PubMed ID: 12171530
    [Abstract] [Full Text] [Related]

  • 4. Strontium ranelate: a novel mode of action optimizing bone formation and resorption.
    Marie PJ.
    Osteoporos Int; 2005 Jan; 16 Suppl 1():S7-10. PubMed ID: 15578159
    [Abstract] [Full Text] [Related]

  • 5. Strontium ranelate improves bone microarchitecture in osteoporosis.
    Hamdy NA.
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv9-13. PubMed ID: 19783592
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Strontium ranelate: a physiological approach for an improved bone quality.
    Ammann P.
    Bone; 2006 Feb; 38(2 Suppl 1):15-8. PubMed ID: 16455318
    [Abstract] [Full Text] [Related]

  • 8. [Strontium Ranelate as a new therapeutic agent for osteoporosis].
    Imanishi Y, Nishizawa Y.
    Clin Calcium; 2005 Jan; 15(1):25-8. PubMed ID: 15632469
    [Abstract] [Full Text] [Related]

  • 9. Strontium ranelate: a physiological approach for optimizing bone formation and resorption.
    Marie PJ.
    Bone; 2006 Feb; 38(2 Suppl 1):S10-4. PubMed ID: 16439191
    [Abstract] [Full Text] [Related]

  • 10. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro.
    Bonnelye E, Chabadel A, Saltel F, Jurdic P.
    Bone; 2008 Jan; 42(1):129-38. PubMed ID: 17945546
    [Abstract] [Full Text] [Related]

  • 11. Strontium ranelate: a new paradigm in the treatment of osteoporosis.
    Reginster JY, Deroisy R, Jupsin I.
    Drugs Today (Barc); 2003 Feb; 39(2):89-101. PubMed ID: 12698204
    [Abstract] [Full Text] [Related]

  • 12. Improvement in bone strength parameters. The role of strontium ranelate.
    Tournis S.
    J Musculoskelet Neuronal Interact; 2007 Feb; 7(3):266-7. PubMed ID: 17947810
    [Abstract] [Full Text] [Related]

  • 13. The intact strontium ranelate complex stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation.
    Yamaguchi M, Weitzmann MN.
    Mol Cell Biochem; 2012 Jan; 359(1-2):399-407. PubMed ID: 21874315
    [Abstract] [Full Text] [Related]

  • 14. [Strontium ranelate's (Osseor) dual mode of action: increasing bone mass and decreasing bone resorption].
    Kaliterna DM.
    Reumatizam; 2008 Jan; 55(2):73-4. PubMed ID: 19024281
    [Abstract] [Full Text] [Related]

  • 15. Osteoblasts play key roles in the mechanisms of action of strontium ranelate.
    Brennan TC, Rybchyn MS, Green W, Atwa S, Conigrave AD, Mason RS.
    Br J Pharmacol; 2009 Aug; 157(7):1291-300. PubMed ID: 19563530
    [Abstract] [Full Text] [Related]

  • 16. Strontium ranelate: a new treatment for postmenopausal osteoporosis with a dual mode of action.
    Reginster JY, Sarlet N, Lejeune E, Leonori L.
    Curr Osteoporos Rep; 2005 Mar; 3(1):30-4. PubMed ID: 16036099
    [Abstract] [Full Text] [Related]

  • 17. Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages.
    Ortolani S, Vai S.
    Bone; 2006 Feb; 38(2 Suppl 1):19-22. PubMed ID: 16455319
    [Abstract] [Full Text] [Related]

  • 18. Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review.
    Gallacher SJ, Dixon T.
    Calcif Tissue Int; 2010 Dec; 87(6):469-84. PubMed ID: 20872215
    [Abstract] [Full Text] [Related]

  • 19. Comprehensive therapy in osteoporosis using a single drug: from ADFR to strontium ranelate.
    Manette C, Collette J, Sarlet N, Tancredi A, Zegels B, Reginster JY.
    Curr Med Chem; 2006 Dec; 13(13):1585-90. PubMed ID: 16787205
    [Abstract] [Full Text] [Related]

  • 20. Potential anti-catabolic and anabolic properties of strontium ranelate.
    Mentaverri R, Brazier M, Kamel S, Fardellone P.
    Curr Mol Pharmacol; 2012 Jun; 5(2):189-94. PubMed ID: 21787286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.